U.S. markets open in 7 hours 9 minutes

Doximity, Inc. (DOCS)

NYSE - NYSE Delayed Price. Currency in USD
19.89-0.19 (-0.95%)
At close: 04:00PM EDT
20.20 +0.31 (+1.56%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close20.08
Bid0.00 x 2900
Ask0.00 x 2200
Day's Range19.79 - 20.36
52 Week Range19.79 - 40.12
Avg. Volume2,135,450
Market Cap3.873B
Beta (5Y Monthly)1.02
PE Ratio (TTM)36.16
EPS (TTM)0.55
Earnings DateNov 17, 2023 - Nov 21, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
56% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for DOCS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Doximity, Inc.
    DOCS: Lowering target price to $21.00DOXIMITY INC-CLASS A has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • Motley Fool

    3 Top Stocks That Just Went on Sale

    Worse yet, Enphase Energy (NASDAQ: ENPH), The Toro Company (NYSE: TTC), and Doximity (NYSE: DOCS) are down between 29% and 53% on the year. Posting a jaw-dropping total return north of 2,700% over the last five years -- even after its drop in 2023 -- Enphase and its semiconductor-based microinverters and batteries have been thriving amid the solar industry's boom. Converting energy at the individual solar module level, Enphase's microinverters are superior to solar systems using a string inverter system, which cannot account for partial shading of a solar panel layout as effectively.

  • Zacks

    Implied Volatility Surging for Doximity (DOCS) Stock Options

    Investors need to pay close attention to Doximity (DOCS) stock based on the movements in the options market lately.

  • Motley Fool

    This Is the Biggest Problem With Doximity's Stock

    Doximity (NYSE: DOCS) operates a networking platform for doctors that claims to have 80% of U.S. physicians on it. It's an impressive statistic, but that hasn't been enough of a reason for investors continue buying up the stock this year. While other growth stocks have been thriving due to artificial intelligence (AI), there's not the same level of excitement around Doximity -- even though the company has launched its own chatbot, DocsGPT.